Apnimed, Inc., a pharmaceutical company developing an oral drug product candidate, AD109, that is designed to address a root cause of obstructive sleep apnea (OSA), today announced that Shionogi & Co.

Shionogi has struck a deal to take full control of its sleep disorder joint venture, agreeing to pay Apnim | Shionogi has ...

Evaluation of a rural pediatric obesity program highlights strengths in structured care delivery while identifying gaps in ...

Firefighters in Seven Hills will sleep easier thanks to a redesign of their sleeping quarters with help from the sleep ...

The itinerary included visits to the Department of Agriculture and the Pentagon, where delegates met Secretary of War Pete ...

The center offers various sleep-away camps for boys, girls and different ages, including Vacation Bible Camp, Blossom: The ...

Experts at SXSW share trends in medicine and longevity, shaping the future of health care and personal wellness.

From the crib to the classroom, local public health nurse Niki Lowrie is working to keep children safe and healthy across ...

The CGH Sleep Center in Sterling was recognized by the American Academy of Sleep Medicine Board of Directors for 25 ...

Caring for infants and young children is challenging in any setting, and military life—with long workdays, frequent ...

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are ...

Therapy for sleep problems includes methods like CBT-I and acupuncture. Connect with a therapist to begin improving your rest ...